enVVeno Medical (NVNO) Competitors $2.85 -0.06 (-2.06%) (As of 10:47 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NVNO vs. NYXH, ARAY, KRMD, SKIN, OBIO, SGHT, INFU, BWAY, PDEX, and NVROShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Nyxoah (NYXH), Accuray (ARAY), KORU Medical Systems (KRMD), Beauty Health (SKIN), Orchestra BioMed (OBIO), Sight Sciences (SGHT), InfuSystem (INFU), BrainsWay (BWAY), Pro-Dex (PDEX), and Nevro (NVRO). These companies are all part of the "surgical & medical instruments" industry. enVVeno Medical vs. Nyxoah Accuray KORU Medical Systems Beauty Health Orchestra BioMed Sight Sciences InfuSystem BrainsWay Pro-Dex Nevro Nyxoah (NASDAQ:NYXH) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, community ranking, profitability, risk, media sentiment, earnings and valuation. Do institutionals & insiders hold more shares of NYXH or NVNO? 34.7% of enVVeno Medical shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 16.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is NYXH or NVNO more profitable? enVVeno Medical has a net margin of 0.00% compared to Nyxoah's net margin of -1,043.93%. enVVeno Medical's return on equity of -48.72% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,043.93% -51.68% -40.11% enVVeno Medical N/A -48.72%-45.96% Does the MarketBeat Community prefer NYXH or NVNO? enVVeno Medical received 118 more outperform votes than Nyxoah when rated by MarketBeat users. However, 71.70% of users gave Nyxoah an outperform vote while only 62.65% of users gave enVVeno Medical an outperform vote. CompanyUnderperformOutperformNyxoahOutperform Votes3871.70% Underperform Votes1528.30% enVVeno MedicalOutperform Votes15662.65% Underperform Votes9337.35% Which has more risk and volatility, NYXH or NVNO? Nyxoah has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Do analysts prefer NYXH or NVNO? Nyxoah presently has a consensus price target of $17.00, indicating a potential upside of 110.92%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings & valuation, NYXH or NVNO? enVVeno Medical has lower revenue, but higher earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$5.08M39.55-$46.77M-$1.87-4.31enVVeno MedicalN/AN/A-$23.52M-$1.29-2.22 Does the media refer more to NYXH or NVNO? In the previous week, enVVeno Medical had 1 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for enVVeno Medical and 2 mentions for Nyxoah. enVVeno Medical's average media sentiment score of 0.14 beat Nyxoah's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral enVVeno Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryenVVeno Medical beats Nyxoah on 9 of the 17 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.03M$4.33B$5.20B$9.14BDividend YieldN/A44.59%5.12%4.29%P/E Ratio-2.2624.5287.0717.11Price / SalesN/A52.161,159.67122.74Price / CashN/A43.4043.2337.85Price / Book0.847.074.804.78Net Income-$23.52M$13.64M$120.46M$225.43M7 Day Performance4.30%-0.90%-0.91%-0.82%1 Month Performance-14.66%-1.55%14.91%1.02%1 Year Performance-40.61%38.74%29.59%15.72% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical2.252 of 5 stars$2.85-2.1%N/A-40.6%$49.98MN/A-2.2119News CoverageGap UpNYXHNyxoah1.7946 of 5 stars$8.00-0.1%$17.00+112.5%+68.4%$199.52M$5.08M-4.28146ARAYAccuray4.5905 of 5 stars$1.87+1.1%$9.00+381.3%-34.8%$188.06M$444.20M-11.00987KRMDKORU Medical Systems1.1766 of 5 stars$3.95-1.7%$4.13+4.4%+66.0%$181.06M$31.99M-15.8080Upcoming EarningsSKINBeauty Health1.8216 of 5 stars$1.44-1.4%$2.55+77.1%-56.2%$178.74M$347.62M-3.431,030OBIOOrchestra BioMed2.0672 of 5 stars$4.69-4.7%$15.75+235.8%-50.6%$178.29M$2.65M-2.9156Positive NewsSGHTSight Sciences3.5252 of 5 stars$3.51-1.7%$5.12+45.9%-3.6%$178.15M$79.54M-3.44210INFUInfuSystem1.3504 of 5 stars$8.15-1.9%$13.00+59.5%N/A$173.30M$132.78M135.86499BWAYBrainsWay3.9774 of 5 stars$9.15-1.0%$13.17+43.9%+29.4%$172.14M$38.63M91.51120Analyst ForecastNews CoveragePDEXPro-Dex2.6291 of 5 stars$45.90-5.8%$52.00+13.3%+166.7%$158.86M$56.80M29.81140NVRONevro2.1843 of 5 stars$3.77-0.5%$6.30+67.1%-82.5%$141.27M$419.15M-1.991,215 Related Companies and Tools Related Companies NYXH Alternatives ARAY Alternatives KRMD Alternatives SKIN Alternatives OBIO Alternatives SGHT Alternatives INFU Alternatives BWAY Alternatives PDEX Alternatives NVRO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NVNO) was last updated on 12/24/2024 by MarketBeat.com Staff From Our Partners"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.